Biofarma Group is a successful industrial project. One year after the merger between Biofarma and Nutrilinea, which gave birth to the new CDMO, the Group closes 2020 with a 10% growth in turnover, despite the health emergency caused by the Coronavirus pandemic.
In this in-depth MilanoFinanza website article, a series of reflections on the Biofarma group's achievements, objectives and future prospects.
> Download pdf
